Outset Medical Inc (NASDAQ: OM) is -85.65% lower on its value in year-to-date trading and has touched a low of $0.44 and a high of $6.37 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The OM stock was last observed hovering at around $0.62 in the last trading session, with the day’s gains setting it 0.16%.
Currently trading at $0.78, the stock is 31.06% and 35.58% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.17 million and changing 25.18% at the moment leaves the stock -67.80% off its SMA200. OM registered -81.99% loss for a year compared to 6-month loss of -76.27%. The firm has a 50-day simple moving average (SMA 50) of $0.56934 and a 200-day simple moving average (SMA200) of $2.42264.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 23.23% gain in the last 1 month and extending the period to 3 months gives it a -15.78%, and is 36.16% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.06% over the week and 8.80% over the month.
Outset Medical Inc (OM) has around 480 employees, a market worth around $40.43M and $114.73M in sales. Profit margin for the company is -122.84%. Distance from 52-week low is 78.41% and -87.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-56.79%).
The EPS is expected to grow by 28.15% this year
156.0 institutions hold shares in Outset Medical Inc (OM), with institutional investors hold 98.08% of the company’s shares. The shares outstanding are 50.32M, and float is at 47.80M with Short Float at 7.26%. Institutions hold 95.97% of the Float.
The top institutional shareholder in the company is FMR LLC with over 7.7 million shares valued at $29.63 million. The investor’s holdings represent 15.1214 of the OM Shares outstanding. As of 2024-06-30, the second largest holder is AMERIPRISE FINANCIAL INC with 5.2 million shares valued at $20.02 million to account for 10.2162 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 3.82 million shares representing 7.4955 and valued at over $14.69 million, while JPMORGAN CHASE & CO holds 6.0385 of the shares totaling 3.07 million with a market value of $11.83 million.
Outset Medical Inc (OM) Insider Activity
The most recent transaction is an insider sale by Trigg Leslie, the company’s Chair and CEO. SEC filings show that Trigg Leslie sold 5,308 shares of the company’s common stock on Aug 15 ’24 at a price of $0.84 per share for a total of $4459.0. Following the sale, the insider now owns 0.91 million shares.
Outset Medical Inc disclosed in a document filed with the SEC on Aug 15 ’24 that Nash Marc (SVP Operations and R&D) sold a total of 1,293 shares of the company’s common stock. The trade occurred on Aug 15 ’24 and was made at $0.84 per share for $1086.0. Following the transaction, the insider now directly holds 0.24 million shares of the OM stock.
Still, SEC filings show that on Aug 15 ’24, Brottem John L. (General Counsel) disposed off 3,011 shares at an average price of $0.84 for $2529.0. The insider now directly holds 230,295 shares of Outset Medical Inc (OM).
